Healthtech startup BeatO has secured INR 42 crore in funding, led by W Health Ventures, to expand its diabetes management solutions and enhance offerings for cardiometabolic conditions.

Information on the Target

BeatO is a healthtech startup that specializes in providing innovative solutions for diabetes management. Founded in 2015 by Yash Sehgal, Abhishek Kumar, and Gautam Chopra, the company has developed a digital care ecosystem designed to offer comprehensive support for individuals dealing with chronic conditions. Through its mobile application, BeatO provides glucose-monitoring solutions, as well as diabetes-specific products such as snacks, specialty foods, and footwear. Additionally, the platform features a marketplace for doctors, educators, diagnostics, medicine refills, and insurance products, all aimed at enhancing the quality of life for those affected by diabetes.

Industry Overview in India

The Indian healthtech market is poised for significant growth, with projections indicating it could reach a size of $21 billion by 2025. This growth is driven by increased awareness of health issues, a rising prevalence of chronic diseases like diabetes, and the emergence of digital solutions that facilitate healthcare accessibility. The government’s push towards digital health initiatives, alongside growing investment from both public and private sectors, presents a conducive environment for healthtech companies to flourish.

Furthermore, the COVID-19 pandemic has accelerated the adoption of telemedicine and digital health solutions, leading to a burgeoning market for healthtech innovations. As patients become more familiar with technology-driven healt